Concepedia

Chengxu Cui

CC

14

Publications

1.4K

Citations

12

H-Index

2011

Active since

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Anhui Medical University

Henan Cancer Hospital

Harbin Medical University

Third Affiliated Hospital of Harbin Medical University

Chengxu Cui is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2011–2023

14

Publications

14

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Zixian Wang, Chengxu Cui, Jun Yao et al. · Cancer Cell · 2022 · 523 citations · Full text

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Shukui Qin, Feng Bi, Shanzhi Gu et al. · Journal of Clinical Oncology · 2021 · 383 citations · Full text

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Jianming Xu, Yi Li, Qingxia Fan et al. · Nature Communications · 2022 · 147 citations · Full text

An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors

Yihebali Chi, Xiaokai Zhan, Hao Yu et al. · Chinese Medical Journal · 2013 · 104 citations · Full text

An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma

Yan‐Xing Chen, Zixian Wang, Ying Jin et al. · Cancer Cell · 2023 · 38 citations · Full text

, , +10

Rows per page

1–5 of 14